研究業績

年別研究業績目録
2005年

英文業績

Original

  1. Junichiro James Kazama, Suguru Yamamoto, Shigemi Kameda, HirokiMaruyama, Ichiei Narita, Takashi Shigematsu, Fumitake Gejyo Directcomparison between two 1-84PTH assays in dialysis patients. NephronClinical Practice 99: c8-c12, 2005
  2. Fumiaki Okahara, Kouichi Itoh, Michihiro Ebihara, MasaoKobayashi, Hiroki Maruyama, Yasunori Kanaho, Tomohiko MaehamaProduction of research-grade antibody by in vivo electroporation ofDNA-encoding target protein. Analytical Biochemistry 336(1): 138-40,2005
  3. Mizuho Sato, Reiko saito, Takatsugu Sakai, Yasuko Sano, MakotoNishikawa, Asami Sasaki, Yugo Shobugawa, Fumitake Gejyo, Hiroshi SuzukiMolecular epidemiology of respiratory syncytial virus infections amongchildren with acute respiratory symptons in a community over threeseasons. Journal of Clinical Microbiology 43(1):36-40, 2005
  4. Junichiro James Kazama, Fuminori Sato, Kentaro Omori, HitomiHama, Suguru Yamamoto, Hiroki Maruyama, Ichiei Narita, Fumitake Gejyo,Takeyoshi Yamashita, Seiji Fukumoto, Masafumi Fukagawa Pretreatmentserum FGF-23 levels predict the efficacy of calcitriol therapy indialysis patients. Kidney International 67(3): 1120-1125, 2005
  5. Bassam Alchi , Shinichi Nishi, Daisuke Kondo, Yoshikatsu Kaneko ,Asako Matsuki , Naofumi Imai, Mitsuhiro Ueno, Seitaro Iguchi, MinoruSakatsume, Ichiei Narita, Tadashi Yamamoto , Fumitake Gejyo Osteopontinexpression in acute renal allograft rejection. Kidney International67(3):886-96, 2005
  6. Hui Liu, Haruo Hanawa, Tsuyoshi Yoshida, Rafat Elnaggar, ManabuHayashi, Ritsuo Watanabe, Ken Toba, Kaori Yoshida, He Chang, YujiOkura, Kiminori Kato , Makoto Kodama, Hiroki Maruyama, JunichiMiyazaki, Mikio Nakazawa, Yoshifusa Aizawa Effect ofhydrodynamics-based gene delivery of plasmid DNA encoding interleukin-1receptor antagonist-Ig for treatment of rat autoimmune myocarditis:possible mechanism for lymphocytes and noncardiac cells.Circuration111(13): 1593-600, 2005
  7. Junichiro James Kazama, Fumitake Gejyo, Isei Ei Theimmunohistochemical localization of a2-Heremans-Schmidglycoprotein/fetuin-A (AHSG). Nephrology Dialysis Transplantation20(4): 851-852, 2005
  8. Hiroki Maruyama, Noboru Higuchi, Shigemi Kameda, Gen Nakamura,Masaaki Shimotori, Noriaki Iino, Masato Higuchi, Tomohiro Neichi,Sadaaki Yokoyama, Toru Kono, Jyun-ichi Miyazaki, Fumitake GejyoSustained transgene expression in rat kidney with naked plasmid DNA andPCR-amplified DNA fragments. Journal of Biochemistry 137(3): 373-380,2005
  9. Nobuyoshi Jinnai, Takuro Sakagami, Takashi Sekigawa, MihoKakihara, Toshiaki Nakajima, Kenichi Yoshida, Shin Goto, TakashiHasegawa, Takeshi Koshino, Yoshinori Hasegawa, Hiromasa Inoue, NaohitoSuzuki, Yasuyuki Sano, Ituro Inoue Polymorphisms in the prostaglandinE2 receptor subtype 2 gene confer susceptibility to aspirin-intolerantasthma: a candidate gene approach. Human Molecular Genetics.13(24):3203-3217, 2005
  10. Yuko Oyama , TetsuroTakeda, Hitomi Hama, Atsuhito Tanuma, NoriakiIino, Kiyoko Sato , Rhohei Kaseda, Meilei Ma , Tadashi Yamamoto,Hiroshi Fujii, Junichiro J Kazama, Shoji Odani, Yoshio Terada, KunihiroMizuta, Fumitake Gejyo, Akihiko Saito Evidence for megalin-mediatedproximal tubular uptake of L-FABP, a carrier of potentially nephrotoxicmolecules. Labopatory Investigation 85(4): 522-531, 2005
  11. Hiroshi Mochizuki, Takamasa Nomura, Ikuo Kawamura, MasaoMitsuyama Enhanced resistance to Gram-positive bacterium and increasedsusceptibility to bacterial endotoxin in mice sensitized withPropinibacterium acnes: involvement of Toll-like receptor. FEMSImmunology and Medical Microbiology 43(2): 287-293, 2005
  12. Daisuke Saga, Minoru Sakatsume, Asa Ogawa, Yutaka Tsubata,Yoshikatsu Kaneko, Takeshi Kuroda, Fuminori Sato, Jyunya Ajiro, DaisukeKondo, T Miida, Ichiei Narita, Fumitake Gejyo Bezafibrate suppressesrat anti-glomerular basement membrane crescentic glomerulonephritis.Kidney International 67(5):1821-1829, 2005
  13. Takeshi Nakatsue, Hiroko Koike, Gi Dong Han, Koichi Suzuki, NaokoMiyauchi, Huaiping Yuan, David Sakant, Fumitake Gejyo, Fujio Shimizu,Hiroshi Kawachi Nephrin and podocin dissociate at the onset ofproteinuria in experimental membranous nephropathy. KidneyInternational 67(6):2239-2253, 2005
  14. Ryoko Machii, Minoru Sakatsume, Ryo Kubota, Shizuko Kobayashi,Fumitake Gejyo, Kiyoko Shiba Examination of the molecular diversity ofalpha(1) antitrypsin in urine: Deficit of an alpha(1) globulin fractionon cellulose acetate membrane electrophoresis. Journal of ClinicalLaboratory Analysis 19(1):16-21, 2005
  15. Raafat Elnaggar, Haruo Hanawa, Hui Liu, Tsuyoshi Yoshida, ManabuHayashi, Ritsuo Watanabe, Satoru Abe, Ken Toba, Kaori Yoshida, HeChang, Shiro Minagawa, Yuji Okura, Kiminori Kato, Makoto Kodama, HirokiMaruyama, Jyunichi Miyazaki, Yoshifusa Aizawa The effect ofhydrodynamics-based delivery of an IL-13-Ig fusion gene forexperimental autoimmune myocarditis in rats and its possible mechanism.Europian Journal of Immunology 35(6): 1995-2005, 2005
  16. Yuko Oyama, Junichiro James Kazama, Kentaro Omori, NoboruHiguchi, Shigemi Kameda, Suguru Yamamoto, Yumi Ito, Hiroki Maruyama,Ichiei Narita, Fumitake Gejyo Pretreatment plasma intact parathyroidhormone and serum calcium levels, but not serum phosphate levels,predict the response to maxacalcitol therapy in dialysis patients withsecondary hyperparathyroidism. Clinical Experimental Nephrology9(2):142-147, 2005
  17. Fumitake Gejyo, Noriyuki Homma, Noboru Higuchi, Ken Ataka, TomokoTeramura, Bassam Alchi, Yukio Suzuki, Shinichi Nishi, Ichiei Narita,The Japanese Society of Nephrology A novel type of encephalopathyassociated with mushroom Sugihiratake ingestion in patients withchronic kidney diseases. Kidney International 68(1):188-192, 2005
  18. Jyunichiro James Kazama, Kentaro Omori, Naoki Takahashi, YosukeIto, Hiroki Maruyama, Ichiei Narita, Fumitake Gejyo Maxacalcitoltherapy decreases circulating osteoprotegerin levels in dialysispatients with secondary hyperparathyroidism. Clinical Nephrology 64(1):64-68, 2005
  19. Takuma Saito, Takashi Yamamoto, Toshihiro Kazawa, Fumitake Gejyo,Makoto Naito Expression of toll-like receptor2 and 4 inlipopolysaccharide-induced lung injury in mouse. Cell and TissueResearch 321(1): 75-88, 2005
  20. Junichiro James Kazama, Hiroki Maruyama, Ichiei Narita, FumitakeGejyo Maxacalcitol is a Possible Less phosphatemic vitamin D analog.Therpeutic Apheresis Dialysis 9: 352-354, 2005
  21. Shohei Nakanishi, Junichiro James Kazama, Tomoko Nii-Kono,Kentaro Omori, Takeyoshi Yamashita, Seiji Fukumoto, Fumitake Gejyo,Takashi Shigematsu, Masafumi Fukagawa Serum fibroblast growth factor-23levels predict the future refractory hyperparathyroidism in dialysispatients. Kidney International 67(3):1171-1178, 2005
  22. Shinichi Nishi, Naofumi Imai, Bassam Alchi, Seitaro Iguchi,Mitsuhiro Ueno, Sachiko Fukase, Honami Mori, Masaaki Arakawa, KazuhideSaito, Kota Takahashi, Fumitake Gejyo The morphological compensatorychange of peritubular capillary network in chronic allograft rejection.Transplantation 9(Suppl 14): 7-11, 2005
  23. Hiroki Maruyama, Jyunichi Miyazaki, Fumitake GejyoEpidermis-targeted gene transfer using in vivo electroporation. Methodsin Moleculer Biology 289:431-436, 2005
  24. Yoko Wada, Takeshi Kuroda, Akira Murasawa , N Tanabe, MasaakiNakano, Fumitake Gejyo Autoantibodies against oxidized low-densitylipoprotein (LDL) and carotid atherosclerosis in patients withrheumatoid arthritis. Clinical Experimental Rheumatology 23(4):482-486, 2005
  25. Hideo Satoh, Takashi Hasegawa, Eiichi Suzuki, Masaaki Terada,Hideaki Nakayama, Shinichi Toyabe, Kouhei Akazawa, Ariyoshi Kondoh,Masaaki Arakawa, Hirohisa Yoshizawa, Fumitake Gejyo Gender differencesin susceptibility of asthma to active smoking -questionnaire basedanalysis in the Niigata prefectuer, Japan-. Allerology International54:(3)401-410, 2005
  26. Fumitoshi Yoshimine, Takashi Hasegawa, Eiichi Suzuki, MasakiTerada, Toshiyuki Koya, Ariyoshi Kondoh, Masaaki Arakawa, HirohisaYoshizawa, Fumitake Gejyo Contribution of aspirin-intolerant asthma tonear fatal asthma based on a questionnaire survey in NiigataPrefecture, Japan. Respirology 10(4): 477-484, 2005
  27. Kunihiko Sakai, Toshinori Takada, Hideaki Nakayama, YukikoKubota, Masami Nakamata, Makoto Sato, Eiichi Suzuki, Kohei Akazawa,Fumitake Gejyo Serotonin-2A and 2C receptor gene polymorphisms inJapanese patients with obstructive sleep anemia. InternalMedicine44(9): 928-933, 2005
  28. Yukiko Kubota, Hideaki Nakayama, Toshinori Takada, NahoMatsuyama, Kunihiko Sakai, Hirohisa Yoshizawa, Masami Nakamata, MakotoSatoh, Kohei Akazawa, Eiichi Suzuki, Fumitake Gejyo Facial axis angleas a risk factor for obstructive sleep apnea. InternalMedicine44(8):805-810, 2005
  29. Satoru Abe, Haruo Hanawa, Manabu Hayashi, Tsuyoshi Yoshida,Satoru Komura, Ritsuo Watanabe, Hui Lie, He Chang, Kiminori Kato,Makoto Kodama, Hiroki Maruyama, Mikio Nakazawa, Junichi Miyazaki,Yoshifusa Aizawa Prevention of experimental autoimmune myocarditis byhidroydynamics-based naked plasmid DNA encoding CTLA4-Ig gene delivery.Journal of Cardiac Failure 11(7):557-563, 2005
  30. Toru Hiura, Hiroshi Kagamu, Satoru Miura, Akira Ishida, HiroshiTanaka, Junta Tanaka, Fumitake Gejyo, Hirohisa Yoshizawa Bothregulatory T cells and antitumor effector T cells are primed in thesame draining lymph nodes during tumor progression. The Journal ofImmunology 5058-5066, 2005
  31. Takashi Harada, Stephen Batsford, Tetsuo Morioka, Jia Yao,Masaaki Arakawa, Fumitake Gejyo, Takashi Oite Establishment ofimmortalized human glomerular endothelial cell lines and theirapplication. Nephron Experimental Nephrology 99(2): e38-e45, 2005
  32. Mizuho Sato, Reiko Saito, Naohito Tanabe, Makoto Nishikawa, AsamiSasaki, Fumitake Gejyo, Hiroshi Suzuki Antibody response to influenzavaccination in nursing home residents and healthcare workers duringfour successive seasons in Niigata, Japan. Infection Control andHospital Epidemiology 26(11): 859-866, 2005
  33. Tadahisa Daimon, Shunji Tajima, Katsuhisa Oshikawa, MasashiBando, Shoji Ohno, Yukihiko Sugiyama KL-6 and surfactant proteins A andD in serum and bronchoalveolar lavage fluid in patients with acuteeosinophilic pneumonia. Internal Medicine 44(8): 811-817, 2005
  34. Takashi Hasegawa, Eiichi Suzuki, Shinichi Toyabe, Kouhei Akazawa,Kenji Kawano, Michihiko Haraguchi, Joji Toyama, Yoko Watanabe, NorikoWatanabe, Masaaki Arakawa, Hiroshi Satoh, Fumitake Gejyo, NiigataInhalation Therapy Study Group Drug compliance in patients withbronchial asthma: Relation among compliance with different types ofantiasthmatic drug and associatino with daily administration frequency.Allergology International 54(4): 547-553, 2005
  35. Takashi Hasegawa, Eiichi Suzuki, Masaki Terada, Toshiyuki Koya,Shinichi Toyabe, Kohei Akazawa, Hirohisa Yoshizawa, Masaaki Arakawa,Fumitake Gejyo Improvement of asthma management in actual practiceconsistent with prevalence of anti-inflammatory agents-based onquestionnaire surveys in Niigata prefecture, Japan from 1998 to 2002-.Allergology International 54(4): 555-563, 2005
  36. Mariko Kawai, Kazuhisa Bessyo, Hiroki Maruyama, Junichi Miyazaki,Toshio Yamamoto Human BMP-2 gene transfer using transcutaneous in vivoelectroporation induced both intramembranous and endochondralossification. The Anatomical Record 287A: 1264-1271, 2005
  37. Masaki Dobashi, Kazumasa Goda, Hiroki Maruyama, Masato FujisawaErythropoietin gene transfer into rat testes by in vivoelectropo-ration may reduce the risk of germ cell loss caused bycryptorchidism. Asian Journal of Andrology 7(4): 369-373, 2005
  38. Masaki Dobashi, Kazumasa Goda, Hiroki Maruyama, Masato FujisawaErythropoietin gene transfer into rat testes by in vivoelectropo-ration may reduce the risk of germ cell loss caused bycryptorchidism. Asian Journal of Andrology 7(4): 369-373, 2005
  39. Shigeru Ohtsubo, Aritoshi Iida, Kosaku Nitta, Toshihiro Tanaka,Ryo Yamada, Yozo Ohnishi, Shiro Maeda, Tatsuhiko Tsunoda, TakashiTakei, Wataru Obara, Fumihiro Akiyama, Kyoko Ito, Kazuho Honda, KeikoUchida, Ken Tsuchiya, Wako Yumura, Takashi Ujiie, Yutaka Nagane, SatoruMiyano, Yasushi Suzuki, Ichiei Narita, Fumitake Gejyo, Tomoaki Fujioka,Hiroshi Nihei, Yusuke Nakamura Association of a single-nucleotidepolymorphism in the immunoglobulin mu-binding protein 2 gene withimmunoglobulin A nephropathy. Journal of Human Genetics50(1):30-35, 2005
  40. Honami Mori, Yoshikatsu Kaneko, Ichiei Narita, SHin Goto, NorikoSaito, Daisuke Kondo, Sato Fuminori, Jyunya Ajiro, Daisuke Saga, AsaOgawa, Minoru Sakatsume, Mitsuhiro Ueno, Kaoru Tabei, Fumitake GejyoRelated Articles, Links Monocyte chemoattractant protein-1 A- 2518Ggene polymorphism and renal survival of Japanese patients withimmunoglobulin A nephropathy. Clinical Experimental Nephrology 9(4):297-303, 2005
  41. Hiroyuki Yamashita, Yuji Yamazaki, Hisashi Hasegawa, TakayoshiYamashita, Seiji Fukumoto, Takashi Shigematsu, Junichiro James Kazama,Masafumi Fukagawa, Shiro Noguchi Fibroblast growth factor-23 inpatients with Grave's disease before and after antithyroid therapy: itsimportant role in serum phosphate regulation. The Journal of ClinicalEndocrinology & Metabolism 90(7): 4211-4215, 2005
  42. Fumihiko Koiwa, Junichiro James Kazama, Akihide Tokumoto,Noritaka Onoda, Hitoshi Kato, Tomoyuki Okada, Tomoko Nii-Kono, MasafumiFukagawa, Takashi Shigematsu ( the ROD21 Clinical Research Group)Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblastgrowth factor 23 levels in dialysis patients. Therapeutic Apheresis andDialysis 9(4): 336-339, 2005
  43. Seigo Yamaguchi, Takashi Hasegawa, Toshiyuki Koya, YasuharuSaito, Jun-ichi Narita, Masaki Terada, Hiroshi Moriyama, HirokiTsukada, Toshinori Takada, Fumitake Gejyo, Eiichi Suzuki Reducedfibrinolytic activity in bronchoalveolar lavage fluids is not relatedto alveolar macrophages in the fibrosis of interstitial pneumonia -ananalysis of bronchoalveolar lavage fluids- Acta Medica et Biologica53(3): 79-86,2005
  44. Masato Makino, Mariko Kawai, Ikuo Kawamura, Masashi Fujita,Fumitake Gejyo, Masao Mitsuyama Involnement of reactive oxygenintermediate in the enhanced expression of virulence-associated genesof Listeria monocytogenes inside activated macrophages. Microbiologyand Immunology 49(8): 805-811, 2005
  45. Yoko Takizawa, Ikue Taneike, Saori Nakagawa, Tomohiro Oishi,Yoshiyuki Nitahara, Nobuhiro Iwakura, Kyoko Ozaki, Misao Takano, TerukoNakayama, and Tatsuo Yamamoto A panton-valentine leucocidin(PVL)-positive community-acquired methicillin-resistant staphylococcusaureus (MRSA) strain, another such strain carrying a multiple-drugresistance plasmid, and other more- typical PVL-negative MRSA strainsfound in Japan. Journal of Clinical Microbiology43(7): 3356-3363, 2005
  46. Chikako Tsubata, Masaya Higuchi, Masahiko Takahashi, MasayasuOie, Yuetsu Tanaka, Fumitake Gejyo, Masahiro Fujii PDZ domain-bindingmotif of human T-cell leukemia virus type 1 Tax oncoprotein isessential for the interleukin 2 independent growth induction of aT-cell line. Retrovirology 2:46, 2005
  47. Daisuke Saga, Minoru Sakatsume, Yoshikatsu Kaneko, YutakaTsubata, Asa Ogawa, Takeshi Kuroda, Junya Ajiro, Fuminori Sato, DaisukeKondo, Ichiei Narita, Fumitake Gejyo The effect of bezafibrate increscentic glomerulonephritis. Nephrology 10(suppl 6): A432, 2005
  48. Koji Kushiya, Saori Nakagawa, Ikue Taneike, Nobuhiro Iwakura,Kenichi Imanishi, Takehiko Uchiyama, Hiroki Tsukada, Fumitake Gejyo,Tatsuo Yamamoto Inhibitory effect of antimicrobial agents andanisodamine on the staphylococcal superantigenic toxin-inducedoverproduction of proinflammatory cytokines by human peripheral bloodmononuclear cells. Journal of Infection and Chemotherapy 11(4): 192-195,2005
  49. F.Safar, T. Kamura, K. Okamuto, K.Sasaki. F.Gejyo Magneticresonance T1 gradient-echo imaging in hepatolithiasis. AbdominalImaging 30: 297-302, 2005

Review

  1. Masafumi Fukagawa, Tomoko Nii-Kono, Junichiro James Kazama Roleof fibroblast growth factor 23 in health and in chronic kidney disease.Mineral Metabolism 14(4)325-329, 2005
  2. Masafumi Fukagawa, Junichiro James Kazama With or without thekidney: the role of FGF23 in CKD. Nephrology Dialysis Transplantation.20(7):1295-1298, 2005
  3. Akihiko Saito, Tetsuro Takeda, Kiyoko Sato, Hitomi Hama, AtsuhitoTanuma, Ryohei Kaseda, Yoshiki Suzuki, Fuimitake Gejyo Significance ofproximal tubular metabolism of advanced glycation end products inkidney diseases. Annals of the New York Academy Sciences1043:637-43,2005
  4. Junichiro James Kazama, Fumitake Gejyo, Shigematsu Takashi,Masafumi Fukagawa Role of circulating fibroblast growth factor 23 inthe development of secondary hyperparathyroidism. Therapeutic ApheresisDialysis 9(4): 328-330, 2005
  5. Suguru Yamamoto, Fumitake Gejyo Historical background andclinical treatment of dialysis-related amyloidosis. Biochemica etBiophysica Acta 1753(1):4-10, 2005
  6. 6. Akihiko Saito, Tetsuro Takeda, Hitomi Hama, Yuko Oyama, KiyokoSato-Hosaka, Atsuhiko Tanuma, Ryohei Kaseda, Mitsuhiro Ueno, ShinichiNishi, Shinya Ogasawara, Yoshiki Suzuki, Fumitake Gejyo Role ofmegalin, a proximal tubular endocytotic receptor, in the pathogenesisof diabetic and metabolic syndrome- related nephropathies: Proteinmetabolic overload hypothesis. Nephrology 10(Suppl):S26-S31, 2005
  7. Suguru Yamamoto, Kazuhiro Hasegawa, Itaru Ymaguchi, Yuji Goto,Fumitake Gejyo, Hironobu Naiki Kinetic analysis of the polymerizationand depolymerization of β2-microglobulin- related amyloid fibrils invitro. Biochimica et Bopchimica Acta 1753(1): 34- 33.2005
  8. Hironobu Naiki, Suguru Yamamoto, Kazuhiro Hasegawa, ItaruYamaguchi, Yuji Goto, Fumitake Gejyo Molecular interactions in theformation and deposition of β2-microglobulin-related amyloid fibrils.Amyloid 12(1): 15-25, 2005

Case Report

  1. Seitaro Iguchi, Bassam Archi, F Safer, A Sakai, K Suzuki, HKihara, M Hirota, Shinichi Nishi, Fumitake Gejyo, Y Ohno Hepatic portalnenous gas associated with noocclusive mesenteric ischemia in ahemodialysis patient. Clinical Nephrology 63(4): 310-3112, 2005
  2. Bassam Alchi, Shinichi Nishi,Seitaro Iguchi, Masaaki Shimotori,Minoru Sakatsume, Mitsuhiro Ueno, Ichiei Narita, Kazuhide Saito, KotaTakahashi, Fumitake Gejyo Recurrent light and heavy chain depositiondisease after renal transplantation. Nephrology DialysisTransplantation 20(7): 1487-1491, 2005